BHV-1100

· Biohaven Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BHV-1100, covering 2025-01-20 to 2025-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients [Phase 1]